Athira Pharma, Inc.

NASDAQ:ATHA

0.328 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -15.003-28.741-26.859-26.337-27.285-32.97-29.597-27.82-30.135-20.189-24.335-20.98-16.339-15.674-13.974-8.866-7.702-8.456-1.992-1.805-0.974-1.53-1.329-1.329
Depreciation & Amortization 0.243-0.2450.2420.2420.2450.2440.2440.2360.2390.2310.2210.1540.1260.1230.1180.1120.2510000.002000
Deferred Income Tax 0000-4.138-0.394-0.4060000000004.1440000000
Stock Based Compensation 2.2292.9363.2052.6792.2282.4943.1192.7822.362.423.0952.7311.4351.1051.1090.9740.4150.1110.0490.0580.0640.0690.060.06
Change In Working Capital -13.5180.9981.188-2.186-1.2546.5882.305-1.11212.175-3.9482.3731.338-3.5454.0265.3350.344-3.543-2.245-0.6630.006-0.2650.3630.0170.017
Accounts Receivables 1.628000-1.628001.2270.473-1.72.2340.102-0.2570.510.317-1.606-7.6100.057-0.057-0.023000
Change In Inventory 00002.33900-2.339-0.4730000000-186.4660000000
Change In Accounts Payables 00.8381.293-3.2540.2086.9491.502-1.2922.1010.5790.2010.1645.151.5953.692-0.3742.6010000000
Other Working Capital -15.1460.16-0.1051.0680.166-0.3610.8031.29210.074-2.827-0.0621.174-8.6954.0265.3350.718187.932-2.245-0.6630.006-0.2650.3630.0170.017
Other Non Cash Items 0.0362.0292.296.2153.9110.0540.053-0.28-0.306-0.1540.0470.1850.1460.1210.0950.131-4.231.179-0.2560.5660.1460.1970.3610.361
Operating Cash Flow -26.013-23.023-22.33-25.804-26.293-23.984-24.282-26.194-15.667-21.64-18.59-16.572-18.177-10.299-7.317-7.305-10.665-9.411-2.862-1.175-1.029-0.901-0.892-0.892
Investing Activities:
Investments In Property Plant And Equipment 00-0.028-0.0050-0.03-0.033-0.241-0.001-0.244-0.151-0.745-1.027-0.128-0.114-0.304-2.255-0.065000000
Acquisitions Net 00000.089-0.021-0.033-0.036-0.025-0.01400-18.052000-0.0680000000
Purchases Of Investments -2.8120-5.411-5.9110-2.78-15.179-9.712-10.171-33.447-33.842-17.828-29.819-95.815-80.42-93.143-132.556-94.281000000
Sales Maturities Of Investments 018.03932.00118.9576.39123.547.69845.47534.81947.32329.53242.41952.21981.74491.98970.73919.0530000.750.24500
Other Investing Activites 0026.5913.0460.0060.0210.0330.0360.0250.014-4.3124.59118.052-14.07111.569-22.4040.068-0.0320.0020.0010.0010.0020.2540.254
Investing Cash Flow -2.81218.03926.56213.0416.39120.6932.48635.52224.64713.632-4.46123.84621.373-14.19911.455-22.708-115.758-94.3130.0020.0010.7510.2470.2540.254
Financing Activities:
Debt Repayment 00000000000000000001.66400.64400
Common Stock Issued 0-0.1480.14800.15200.2420.0990.65400.2970.21-96.4350.125-0.2697.17221.293187.224000000
Common Stock Repurchased 00000000000000-0.26000000000
Dividends Paid 000000000000000000000000
Other Financing Activities 0.0340.0120.14800.15200.2420.0990.14700.2970.210.0130.1250.150.0390.03-2.94185.3040.1760.0540.0060.1210.121
Financing Cash Flow 0.0340.0120.14800.15200.2420.0990.14700.2970.210.0130.125-0.2697.21121.323184.28385.3041.840.0540.650.1210.121
Other Information:
Effect Of Forex Changes On Cash 000019.730-5.32700000000000000000
Net Change In Cash -28.791-4.9724.38-12.763-19.75-3.2948.4469.4279.127-8.008-22.7547.4843.209-24.3733.87867.198-105.180.55982.4440.666-0.224-0.004-0.517-0.517
Cash At End Of Period 49.06977.8682.20177.82190.584110.965114.259105.81396.38687.25995.267118.021110.537107.328131.701127.82360.625165.72585.1662.7222.0562.282.284-0.517